Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 2.

Journal Article

Galle, P. R., Kim, R. D., Sung, M. W., Harris, W. P., Waldschmidt, D., Cabrera, R., Mueller, U., Nakajima, K., Ishida, T. and El-Khoueiry, A. B. (2020). Updated results of a phase Ib study of regorafenib (REG) plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC). Ann. Oncol., 31. S. S691 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041

Waldschmidt, D., El-Khoueir, A. B., Kim, R. D., Harris, W. P., Sung, M. W., Iqbal, S., Zhang, A., Nakajima, K. and Galle, P. R. (2020). Phase 1b study of regorafenib (REG) plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC). Oncol. Res. Treat., 43 (SUPPL 4). S. 123 - 124. BASEL: KARGER. ISSN 2296-5262

This list was generated on Sun May 16 04:51:33 2021 CEST.